Related Experiment Videos
Identification of a novel site specific endonuclease produced by Mycoplasma fermentans: discovery while
N F Halden1, J B Wolf, W J Leonard
1Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892.
Abstract:
We have discovered a new restriction endonuclease, MfeI, in nuclear extracts from T cells contaminated with Mycoplasma fermentans. This endonuclease was identified while studying proteins binding to the interleukin-2 receptor alpha chain gene promoter. MfeI cuts at the recognition sequence C'AATTG generating EcoRI compatible cohesive ends. Potential applications are discussed.
Insights
A novel restriction enzyme, MfeI, was found in T cell nuclear extracts. This enzyme, MfeI, cuts DNA at a specific sequence, yielding ends compatible with EcoRI restriction enzyme.
Area of Science:
- Molecular Biology
- Enzymology
- Immunology
Background:
- Restriction endonucleases are crucial tools in molecular biology for DNA manipulation.
- Mycoplasma contamination can introduce unexpected enzymatic activities into biological samples.
- Understanding gene regulation requires identifying proteins that bind to specific DNA sequences, such as the interleukin-2 receptor alpha chain gene promoter.
Purpose of the Study:
- To identify and characterize a novel restriction endonuclease discovered in T cell nuclear extracts.
- To determine the specific DNA recognition sequence and cutting site of the new enzyme.
- To explore the potential applications of this novel restriction enzyme.
Main Methods:
- Nuclear extracts from T cells contaminated with Mycoplasma fermentans were analyzed.
- Enzyme activity was detected and isolated.
- The recognition sequence and cleavage site of the endonuclease were determined.
- Compatibility of generated ends with known restriction enzymes was assessed.
Main Results:
- A new restriction endonuclease, named MfeI, was discovered.
- MfeI recognizes and cuts the DNA sequence C'AATTG.
- The enzyme generates cohesive ends that are compatible with those produced by EcoRI.
- The discovery occurred during the investigation of proteins binding to the interleukin-2 receptor alpha chain gene promoter.
Conclusions:
- MfeI represents a newly identified restriction endonuclease with potential utility in molecular biology.
- The enzyme's ability to generate EcoRI-compatible ends suggests applications in cloning and DNA manipulation.
- Further research is warranted to fully elucidate MfeI's properties and applications.